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INDUCTION OF OVULATION IN THE HUMAN WITH HUMAN GONADOTRO-
PINS.* By C. Lee Buxton and Walter Herrmann, Department of Obstetrics
and Gynecology, Yale University School of Medicine.
During the 33 years since human chorionic gonadotropin (hereafter to be
designated as HCG) was shown to produce ovulation in small mammals,
there have been numerous unsatisfactory attempts to stimulate human
ovarian activity by various gonadotropin extracts.2 Recent evidence of
successful species specific gonadotropin extract administration in the
monkey and human has been presented by van Wagenen and Simpson8
and by Gemzell.'
The extract used by injection in the present series (HPG)** was
obtained from human autopsy material, regardless of the age or sex of
the subject. This was prepared by extracting the lyophilized pituitary glands
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FIG. 1. Summary of endocrine status of eight patients.
with 40 per cent ethanol and precipitating the extractable material with
higher concentrations of ethanol. The precipitate was redissolved, dialyzed,
lyophilized and assayed. A later batch (used in J.J.) was purified on an ion
exchange column, permitting the removal of most of the LH activity and
increasing its FSH activity approximately threefold.
Seventeen courses of injections were given to eight patients, following a
course of concentrated chorionic gonadotropin. The latter hormone has
been unsuccessfully used in humans by many investigators2 and its inability
to induce ovulation seems to be well established. Nevertheless, since it
would appear necessary to control a possible psychogenic effect of the
* The authors wish to acknowledge the advice and cooperation of Drs. van Wagenen
and Simpson throughout the process of this study.
** HPG was provided through the courtesy of Merck & Co., Rahway, N. J., in
cooperation with Dr. Miriam Simpson, Berkeley, California, who was responsible for
the original preparation and assaying of the material. A later batch used in Patient J.P.
had been prepared by Dr. S. L. Steelman of Merck & Co.
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present therapy, particularly in patients suffering from hypothalamic
amenorrhea, it was felt that the present design would control this aspect and
also eliminate HCG alone as the substance responsible for ovulation, should
this occur. The patients were evaluated by the means of basal body tempera-
ture charts, endometrial biopsies, vaginal smears, and in one case by
culdoscopy. They have all been amenorrheic, either primarily or from three
to six years. They had various diagnoses, as designated in Figure 1, and all
had had thorough endocrine investigations.
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FIG. 2. Result of treatment of eight patients with human pituitary extract and human
chorionic gonadotropin.
As is seen in Figure 2, one patient (A.R.) after three years of amenorrhea,
ovulated and menstruated following each of the two courses of HCG alone
and, as a matter of fact, has continued to menstruate and ovulate since, a
result quite different from all of the others. The remaining patients failed to
ovulate or menstruate following HCG therapy alone and they therefore
were considered appropriate cases to be treated with the combination of
HPG and HCG, using a technique and dosage schedule as originally
designed by van Wagenen and Simpson for the monkey and adapted to
the human on a weight by weight basis. Several variations of therapy were
tried at first, before establishing what was considered to be the most satis-
factory method. This proved to be the priming of the follicle by administra-
tion of 10 mg. of HPG, b.i.d. for four days, followed by four days of
administration of HPG, 10 mg., plus HCG, 8,000 units b.i.d. As the more
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potent extract became available (see above, Patient J.J.) an attempt was
made to decrease the number of injections and amount of hormone given.
The results are apparent in Figure 2. The presence of ovulation was
established by the typical changes in the basal body temperature, as well as
by secretory transformation of the endometrium. In one patient (A.P.)
formerly diagnosed as anorexia nervosa, further documentation was
obtained through direct inspection of the ovaries by culdoscopy. This dis-
closed an enlargement of the ovaries to what was judged to be about three
times the normal size, with at least three areas observed in each ovary that
were raised above the surface; three were about 1 cm. in diameter and dark
purplish or bluish in color, each having at the apex a hemorrhagic stoma.
This latter finding is quite similar to the observation of van Wagenen and
Simpson in the monkey and of Gemzell in the human.
In summary, seven amenorrheic women were given 15 series of injections
of human pituitary material, consisting of human pituitary extract (HPG)
combined in part with chorionic gonadotropin (HCG). There were two
failures of therapy; one was a patient diagnosed as congenital adrenal hyper-
plasia, age 33, who had had, at the age of 11, a resection of ovarian tissue
and subsequent prolonged treatment with various steriods, primarily of the
cortisone series. The other patient responded to the therapy by uterine
bleeding, but without evidence of ovulation. She was diagnosed as a Chiari-
Frommel syndrome (amenorrhea, galactorrhea, low estrogen). However, she
did not receive the full course of therapy, which had proved to be successful
in subsequent cases. The other patients, amenorrheic primarily, or for from
three to six years, responded to therapy by uterine bleeding from secretory
endometrium and had basal body temperature charts characteristic of
progestational activity. It was therefore assumed that they had ovulated.
Onepatient, who was subjected to culdoscopy, appeared tohave at least three
ovulation points in each ovary. These findings are in agreement with the
experiments of van Wagenen and Simpson in Macaca mulatta and of
Gemzell in the human.
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